Oral and Perioral Herpes Simplex Virus Infection Type I in a Five-month-old Infant: A Case Report
NCT04713423 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1
Last updated 2021-01-19
Summary
A five-month-old healthy girl who presented with painful herpetic gingivostomatitis and perioral vesicles.
Conditions
- Herpes Simplex Virus Infection
Interventions
- DIAGNOSTIC_TEST
-
Diagnosis and treatment of the case
The infant was transferred to a hospital for better management of her infection. She was immediately started on intravenous acyclovir (20 mg/kg/6 h/5 d) while acetaminophen suppositories (80 mg/8 h/5 d) were given to lower her body temperature. In addition, other palliative drugs, such as diphenhydramine syrup (12.5 mg/5 mL, 2.5 mL orally) once-a-night for five days, were given to ease the effort of drinking and to aid in achieving good sleep. Upon completion of five days of therapy, the patient showed complete recovery and was subsequently discharged from the hospital free from symptoms.
Sponsors & Collaborators
-
Princess Nourah Bint Abdulrahman University
lead OTHER
Principal Investigators
-
Ashwag Y Aloyouny · Princess Nourah Bint Abdulrahman University
Eligibility
- Sex
- FEMALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2017-10-19
- Primary Completion
- 2017-10-19
- Completion
- 2017-10-19
Countries
- Saudi Arabia
Study Locations
More Related Trials
-
Acyclovir for Herpes Infections Involving the Central Nervous System in Neonates
NCT00031460 ·Status: COMPLETED ·Phase: PHASE3
-
Bethaherpesviruses in Children Who Are Immune Suppressed
NCT00641121 ·Status: COMPLETED
-
Phase III Randomized Study of Oral Acyclovir in Infants With Herpes Simplex Virus Infection Involving the Central Nervous System
NCT00006132 ·Status: UNKNOWN ·Phase: PHASE3
-
A Safety and Dose-Determining Study of CMX001 In Infants With Neonatal Herpes Simplex Virus (HSV) Infection Involving the Central Nervous System (CNS Disease)
NCT01610765 ·Status: WITHDRAWN ·Phase: PHASE1/PHASE2
-
A Study to Investigate the Efficacy, Safety and Tolerability of PEG in Patients With Genital Herpes
NCT01765114 ·Status: TERMINATED ·Phase: PHASE2
-
Study to Compare Safety and Immunogenicity of Commercial Scale Consistency Lots of Herpes Simplex Vaccine
NCT00224471 ·Status: COMPLETED ·Phase: PHASE3
-
Phase I/II Study of High-Dose Acyclovir for Central Nervous System or Disseminated Neonatal Herpes Simplex Virus Infection
NCT00004644 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Hand Sanitizer Use for Herpes Simplex Virus-1
NCT06135844 ·Status: RECRUITING ·Phase: EARLY_PHASE1
-
Safety and Efficacy Study of a New Treatment for Recurrent Symptoms of Oral Herpes Virus Infection
NCT01308424 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Effect of HSV-2 Suppressive Therapy on Sexual Behavior
NCT00495716 ·Status: TERMINATED ·Phase: PHASE4
-
A Study to Describe the Pharmacokinetics of Acyclovir in Premature Infants (PTN_Acyclo)
NCT00942084 ·Status: COMPLETED ·Phase: PHASE1
-
Comparison of Topical Antiviral Agents for Labial Cold Sores (Herpes Labialis)
NCT00467662 ·Status: UNKNOWN ·Phase: PHASE4
-
Valacyclovir in Neonatal Herpes Simplex Virus Disease
NCT04448392 ·Status: COMPLETED ·Phase: PHASE1
-
Evaluation of Cold Sore Treatments on Ultra Violet (UV) Induced Cold Sores
NCT01902303 ·Status: COMPLETED ·Phase: PHASE2
-
A Study on the Reactogenicity, Safety and Immune Response of a Targeted Immunotherapy Against HSV in Healthy Japanese Participants Aged 18-40 Years
NCT05989672 ·Status: COMPLETED ·Phase: PHASE1
-
Acyclovir Therapy for Genital Herpes Ulcers in HIV Negative African Women
NCT02053142 ·Status: COMPLETED ·Phase: NA
-
A Study to Evaluate the Safety and Efficacy of Single Day or Single Dose Famciclovir for the Treatment of Recurrent Herpes Labialis
NCT00248144 ·Status: COMPLETED ·Phase: PHASE4
-
Place Controlled Study to Treat Recurrent Herpes Labialis.
NCT00914745 ·Status: COMPLETED ·Phase: PHASE2
-
Herpevac Neonatal Substudy
NCT00138320 ·Status: TERMINATED
-
Herpes Simplex Reactivation in Adult Critical Care Patients
NCT02322476 ·Status: UNKNOWN
-
Safety, Pharmacokinetics, and Efficacy Study of NB-001 to Treat Recurrent Herpes Labialis
NCT00453401 ·Status: COMPLETED ·Phase: PHASE2
-
A 48 Week Observational Study of the Frequency of Symptomatic Herpes Virus I and II in HIV Infected Subjects
NCT05823779 ·Status: UNKNOWN
-
Safety, Tolerability and Therapeutic Efficacy of Topical ZEP-3 Ointment (1.0%) for the Treatment of Cold Sores
NCT02483182 ·Status: COMPLETED ·Phase: PHASE2
-
Should We Use Oral Valacyclovir in Acute Herpetic Gingivostomatitis in Children?
NCT02738229 ·Status: COMPLETED ·Phase: PHASE2
-
Immune Response and General Immune Health in Subjects Infected With Herpes Simplex Virus Type 1 (HSV-1)
NCT03661541 ·Status: COMPLETED ·Phase: PHASE1